The Shining Future of Accurate Mass Quantitation for Small and Large Molecules

This is the 2nd presentation in a brand new series of 4 webinars brought to you by Bioanalysis and Waters Corporation on ‘Opportunities in a Changing Landscape: Innovative LC/MS Solutions that will Usher in the Future of DMPK.’

In this webinar Chris Evans, Pharmaceuticals Director at GlaxoSmithKline discussed ‘The Shining Future of Accurate Mass Quantitation for Small and Large Molecules.’

We hope you enjoy this presentation and if you have any questions for the speakers or host please do contact us by emailing [email protected].

The webinar series will tackle 4 important topics facing the DMPK laboratory today that you don’t want to miss! Other webinars in this series include:

• The Analysis of Teriparatide by LC-MS/MS – The Challenges and Lessons Learned presented by Elizabeth Thomas, Vice President and General Manager UK Bioanalytical Operations at ICON.

• Protein and Peptide Therapeutics: Addressing bioanalytical demands of complicated peptides presented by Erin Chambers, Principal Applications Chemist at Waters.

• Innovation is not dead in DMPK – New platforms that deliver the future for Pharma presented by Mark Wrona, Principal Applications Chemist at Waters.